They also demonstrated that perifosine, an Akt inhibitor, could suppress both in vivo tumorigenicity and the in vitro ALDH+ population of a breast cancer cell line and two xenografts of primary breast cancer [46]. Here, AKT1 is linked to breast carcinoma.